T cells are very potent cancer-fighting cells in our immune system, and are often used in cell-based immunotherapies. Dr. Gerlach is helping to decipher their various identities and behaviors. She is searching for markers on the T cells that delineate cells with different functional properties.
Harvard Medical School | All Cancers | 2014 | Ulrich H. von Andrian, M.D.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
July is Sarcoma Awareness Month. As a rare and difficult-to-treat form of cancer, effective drug treatments are urgently needed and immunotherapy for sarcoma shows promise.
Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research and the recently launched partnership with CRI.